Ledger.Open graph →
SEC Form D · Amendment · filed August 14, 2024

GelSana Therapeutics, Inc

Offering
$3.2M
Sold
$2.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
AURORA, CO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Mike Freeman · Aurora, CODirectorMelissa Krebs · Aurora, COExec · DirectorDiana Verrilli · Aurora, CODirectorMike Freeman · Aurora, CODirectorMelissa Krebs · Aurora, COExec · DirectorDiana Verrilli · Aurora, CODirectorJon Fernandez · Aurora, COExecDan Fipke · Houston, TXDirectorJake Bainbridge · Houston, TXExec · DirectorJohn V. Harris · Cleveland, OHDirectorJon Fernandez · Aurora, COExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗